Manuel Krone
Biographic Data
| ID | 7922540 |
|---|---|
| NAME | Manuel Krone |
| GIVEN NAMES | Manuel |
| FAMILY NAME | Krone |
| SIGNATURE | KRONE M |
| AFFILIATIONS | University of Würzburg |
| ORCID | 0000-0002-1020-6454 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Respiratory syncytial virus
Human respiratory syncytial virus (RSV), a leading cause of serious respiratory illness, can affect individuals of all ages, especially children below two years of age and adults 60 years of age and above, as well as individuals with chronic comorbidities, such as chronic pulmonary or cardiovascular conditions, and immunocompromised individuals [1,2]. In adults, clinical outcomes [...]
High Seroprevalence of Sars-CoV-2 in Mwanza, Northwestern Tanzania
The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence studies is important in designing control and preventive strategies in communities. This study investigated the seropositivity of the SARS-CoV-2 virus…
No prominent works on this page.
High Seroprevalence of Sars-CoV-2 in Mwanza, Northwestern Tanzania
The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence studies is important in designing control and preventive strategies in communities. This study investigated the seropositivity of the SARS-CoV-2 virus…
Respiratory syncytial virus
Human respiratory syncytial virus (RSV), a leading cause of serious respiratory illness, can affect individuals of all ages, especially children below two years of age and adults 60 years of age and above, as well as individuals with chronic comorbidities, such as chronic pulmonary or cardiovascular conditions, and immunocompromised individuals [1,2]. In adults, clinical outcomes [...]
Internal Medicine (2 works) · Medicine (2 works) · 2019-20 coronavirus outbreak (1 work) · Antibody (1 work) · COVID-19 Clinical Research Studies (1 work) · Cross-sectional study (1 work) · Environmental health (1 work) · Geography (1 work) · Immunology (1 work) · Interquartile range (1 work)